Trials / Terminated
TerminatedNCT00092833
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
An Open-Label, Worldwide, Treatment Use Study to Provide Ezetimibe 10 Mg/Day to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia (high cholesterol) or sitosterolemia (unusually high absorption of non-cholesterol sterols) in a treatment use setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Comparator: ezetimibe | Ezetimibe (MK0653) 10 mg once daily for 3 years. |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2005-05-01
- Completion
- 2005-05-01
- First posted
- 2004-09-28
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092833. Inclusion in this directory is not an endorsement.